Entrada Therapeutics, Inc. TRDA
4.35 USD -0.29 (-6.25%)
Regular-session close
4.20 -0.15 -3.45%
After hours · Nov 20, 4:36 PM ET
4.32 Day range 4.58
4.35 52-week range 16.03
- YTD
- -57.68%
- 1 year
- -52.56%
News
benzinga.com Guggenheim Maintains Buy on Entrada Therapeutics, Lowers Price Target to $13 Guggenheim analyst Debjit Chattopadhyay maintains Entrada Therapeutics (NASDAQ:TRDA) with a Buy and lowers the price target from $17 to $13.
globenewswire.com Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics' ELEVATE-45-201 Study -- ELEVATE-45-201 Cohort 2 (10 mg/kg) enrollment complete with data expected in H1 2027 -- BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that an…benzinga.com Entrada Therapeutics Q3 EPS $(0.94) Beats $(1.01) Estimate, Sales $905.000K Miss $5.871M Estimate Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(1.01) by 6.93 percent. This is a 11.32 percent increase over losses of…
